PortfoliosLab logoPortfoliosLab logo
NBTK.DE vs. GN0M.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NBTK.DE vs. GN0M.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NBTK.DE achieves a 4.27% return, which is significantly lower than GN0M.DE's 12.99% return.


NBTK.DE

1D
2.92%
1M
0.38%
YTD
4.27%
6M
3.76%
1Y
39.20%
3Y*
9.94%
5Y*
5.63%
10Y*

GN0M.DE

1D
5.61%
1M
11.50%
YTD
12.99%
6M
9.82%
1Y
55.73%
3Y*
-1.90%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NBTK.DE vs. GN0M.DE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
NBTK.DE
Invesco Nasdaq Biotech UCITS ETF
4.27%18.60%4.57%2.51%-6.11%-0.88%
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
12.99%5.67%-12.40%-9.04%-32.50%-7.90%

Correlation

The correlation between NBTK.DE and GN0M.DE is 0.82, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.82

Correlation (3Y)
Calculated over the trailing 3-year period

0.82

Correlation (All Time)
Calculated using the full available price history since Nov 12, 2021

0.82

The correlation between NBTK.DE and GN0M.DE has been stable across timeframes, ranging from 0.82 to 0.82 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NBTK.DE vs. GN0M.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBTK.DE
NBTK.DE Risk / Return Rank: 7171
Overall Rank
NBTK.DE Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
NBTK.DE Sortino Ratio Rank: 6363
Sortino Ratio Rank
NBTK.DE Omega Ratio Rank: 5656
Omega Ratio Rank
NBTK.DE Calmar Ratio Rank: 9292
Calmar Ratio Rank
NBTK.DE Martin Ratio Rank: 8484
Martin Ratio Rank

GN0M.DE
GN0M.DE Risk / Return Rank: 5858
Overall Rank
GN0M.DE Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
GN0M.DE Sortino Ratio Rank: 6161
Sortino Ratio Rank
GN0M.DE Omega Ratio Rank: 5454
Omega Ratio Rank
GN0M.DE Calmar Ratio Rank: 6868
Calmar Ratio Rank
GN0M.DE Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBTK.DE vs. GN0M.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NBTK.DEGN0M.DEDifference
Sharpe ratioReturn per unit of total volatility

+0.02

Sortino ratioReturn per unit of downside risk

+0.05

Omega ratioGain probability vs. loss probability

1.34

1.33

+0.01

Calmar ratioReturn relative to maximum drawdown

6.16

3.32

+2.84

Martin ratioReturn relative to average drawdown

17.06

8.35

+8.70

NBTK.DE vs. GN0M.DE - Sharpe Ratio Comparison

The current NBTK.DE Sharpe Ratio is 2.03, which is comparable to the GN0M.DE Sharpe Ratio of 2.00. The chart below compares the historical Sharpe Ratios of NBTK.DE and GN0M.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NBTK.DEGN0M.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.03

2.00

+0.02

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

0.42

-0.34

+0.76

Drawdowns

NBTK.DE vs. GN0M.DE - Drawdown Comparison

The maximum NBTK.DE drawdown since its inception was -30.99%, smaller than the maximum GN0M.DE drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and GN0M.DE.


Loading charts...

Drawdown Indicators


NBTK.DEGN0M.DEDifference

Max Drawdown

Largest peak-to-trough decline

-30.99%

-67.19%

+36.20%

Max Drawdown (1Y)

Largest decline over 1 year

-6.24%

-16.68%

+10.44%

Max Drawdown (3Y)

Largest decline over 3 years

-29.35%

-48.19%

+18.84%

Max Drawdown (5Y)

Largest decline over 5 years

-30.99%

Current Drawdown

Current decline from peak

-1.44%

-41.03%

+39.59%

Average Drawdown

Average peak-to-trough decline

-10.62%

-43.13%

+32.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.26%

6.65%

-4.39%

Volatility

NBTK.DE vs. GN0M.DE - Volatility Comparison

The current volatility for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) is 6.41%, while Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a volatility of 8.15%. This indicates that NBTK.DE experiences smaller price fluctuations and is considered to be less risky than GN0M.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NBTK.DEGN0M.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.41%

8.15%

-1.74%

Volatility (6M)

Calculated over the trailing 6-month period

14.11%

19.69%

-5.58%

Volatility (1Y)

Calculated over the trailing 1-year period

19.00%

27.68%

-8.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.30%

31.49%

-11.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.05%

31.49%

-9.44%

NBTK.DE vs. GN0M.DE - Expense Ratio Comparison

NBTK.DE has a 0.40% expense ratio, which is lower than GN0M.DE's 0.50% expense ratio.


Dividends

NBTK.DE vs. GN0M.DE - Dividend Comparison

Neither NBTK.DE nor GN0M.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


NBTK.DE and GN0M.DE have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, NBTK.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.

NBTK.DE is cheaper with a 0.40% expense ratio, compared with 0.50% for GN0M.DE.

NBTK.DE tracks Nasdaq Biotechnology, while GN0M.DE tracks Solactive Genomics. They also come from different issuers: Invesco and Global X. Their fees differ too: 0.40% for NBTK.DE and 0.50% for GN0M.DE.

Portfolio Optimizer

Find the right allocation for NBTK.DE and GN0M.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer